Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/CTRI/2023/08/056351
CTRI/2023/08/056351Not yet recruitingPhase 3

A COMPARITIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF PATALGARUDI DISPERSABLE TABLET IN THE MANAGEMENT OF LOWER URINARY TRACT INFECTION WITH NITROFURANTOIN

Dr AARTI SAINI1 site in 1 country40 target enrollmentStarted: August 20, 2023Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor
Enrollment
40
Locations
1
Primary Endpoint
WILL SUBSIDE THE SYMPTOMS OF URINARY TRACT INFECTION
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

Aim

To evaluate the efficacy of Patalgarudi dispersible tablet in the management of lower urinary tract infection

Objectives

To observe the efficacy of Patalgarudi dispersible tablet in the management of lower urinary tract infection

To evaluate the clinical efficacy of Patalgarudi on urine biochemical parameters

To evaluate antibacterial property of Patalgarudi dispersible tablet in vitro study

Study Design

Study Type
Interventional
Allocation
Computer generated randomization
Masking
Open Label

Eligibility Criteria

Ages
20.00 Year(s) to 70.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • •Patients presenting with LUTI Any of two or more symptoms described in the context of LUTI Patients irrespective of gender caste and religion Patient between the age group of 20 70 years.

Exclusion Criteria

  • •Below the 20 years or above 70 years Hematuria Renal failure Pyelonephritis Nephrotic syndrome Septicemia Chronic systemic illness uncontrolled DM and HTN HIV Malignancy HBsAg TB.

Outcomes

Primary Outcomes

WILL SUBSIDE THE SYMPTOMS OF URINARY TRACT INFECTION

Time Frame: 21 DAYS

Secondary Outcomes

  • WILL SUBSIDE THE SYMPTOMS OF LOWER URINARY TRACT INFECTION(Dysuria)

Investigators

Sponsor
Dr AARTI SAINI
Sponsor Class
Other [self]

Study Sites (1)

Loading locations...

Similar Trials

Withdrawn
Not Applicable
GAG Replacement vs URethral DIlAtatioNRecurrent Urinary Tract Infection
NCT03861260Hampshire Hospitals NHS Foundation Trust
Completed
Phase 3
Sling vs Botox for Mixed IncontinenceUrinary Incontinence, StressUrinary Incontinence, Urge
NCT04171531NICHD Pelvic Floor Disorders Network150
Completed
Phase 4
Ultrasound-Guided 5% Dextrose Injection for Carpal Tunnel SyndromeCarpal Tunnel Syndrome
NCT06349265Kastamonu University33
Completed
Phase 4
Arsucam® (Artesunate + Amiodaquine) Efficacy and TOLeranceMalaria
NCT00445796Sanofi300
Recruiting
Phase 1/2
A study to reveal better drug of choice between Yashtimadhu Ghrita and Yashtimadhu Ghrita for treatment of Anal-Fisure
CTRI/2020/01/022856Dr Bhardwaj Bhosekar30